Applications of high-throughput DNA sequencing to benign hematology
about
Human and murine erythropoiesisErythro-megakaryocytic transcription factors associated with hereditary anemiaUnsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users' viewsWhole-Exome Sequencing Identifies Loci Associated with Blood Cell Traits and Reveals a Role for Alternative GFI1B Splice Variants in Human Hematopoiesis.Global transcriptome analyses of human and murine terminal erythroid differentiation.Diagnostic approaches for inherited hemolytic anemia in the genetic eraGlobal transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes.X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation.Altered chromatin occupancy of master regulators underlies evolutionary divergence in the transcriptional landscape of erythroid differentiationInsight into GATA1 transcriptional activity through interrogation of cis elements disrupted in human erythroid disordersExome sequencing results in successful diagnosis and treatment of a severe congenital anemia.Society for Pediatric Research 2015 Young Investigator Award: genetics of human hematopoiesis-what patients can teach us about blood cell production.From helix to hematology: introduction to a collection of reviews on the emerging role of next-generation sequencing in hematology.Whole-exome sequencing identifies an α-globin cluster triplication resulting in increased clinical severity of β-thalassemia.Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload.Translational Research: From Biological Discovery to Public Benefit (or Not)
P2860
Q27023709-7ADA10F7-40AA-43FF-9010-6F1A3F6EB204Q28236415-9A94B50D-BD19-4399-B4A3-E353F04CF67EQ28597904-85AFA51F-E298-4F7B-9803-0AA03BB54B99Q30276209-F7C1FCF5-066D-43CF-852F-07F002177F33Q33697238-D17621C0-8783-4649-BDB0-E4A5A9CD7E27Q33889987-8E5C846F-1301-49DF-9BD0-ACC5B974D93BQ34444243-B5403152-FA2D-42FB-99AF-B0F0643129D4Q35408822-7110C5F9-6C9E-49CA-A56B-1B67F0B660D3Q35529339-3A20AED3-BA08-4653-9A92-0D14B1EC1776Q36831545-AFBB15CF-F7D1-400B-9467-15043A15461FQ37188684-AC61FA85-4C97-4E1C-8389-2FEFF1D0936CQ38635450-63699D3B-4CA3-42B8-B43E-B54067F58BD9Q42916400-2FE1FA12-EBFC-4807-9203-A1352CC00CD1Q47131108-CEB5AF8D-46DB-42E8-96E7-2C21B81CE1CFQ53199534-AD592365-56B3-41C7-8AF1-E60124611C89Q59042590-FA4A8B72-21D0-4432-A7CF-532108F44B60
P2860
Applications of high-throughput DNA sequencing to benign hematology
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Applications of high-throughput DNA sequencing to benign hematology
@en
Applications of high-throughput DNA sequencing to benign hematology.
@nl
type
label
Applications of high-throughput DNA sequencing to benign hematology
@en
Applications of high-throughput DNA sequencing to benign hematology.
@nl
prefLabel
Applications of high-throughput DNA sequencing to benign hematology
@en
Applications of high-throughput DNA sequencing to benign hematology.
@nl
P2860
P1433
P1476
Applications of high-throughput DNA sequencing to benign hematology
@en
P2093
Patrick G Gallagher
Vijay G Sankaran
P2860
P304
P356
10.1182/BLOOD-2013-07-460337
P407
P577
2013-09-10T00:00:00Z